The eortc randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: Long-term results and side effects
Keyword(s):
1995 ◽
Vol 35
(2)
◽
pp. 91-99
◽
Keyword(s):
2013 ◽
Vol 87
(2)
◽
pp. S57
◽
Keyword(s):
Keyword(s):
1982 ◽
Vol 8
(9)
◽
pp. 1525-1531
◽
2001 ◽
Vol 24
(6)
◽
pp. 553-558
◽
Keyword(s):
2008 ◽
Vol 70
(5)
◽
pp. 1382-1388
◽
Keyword(s):
Keyword(s):